JCR Pharmaceuticals Co Ltd - Company Profile
Powered by 
All the sales intelligence you need on JCR Pharmaceuticals Co Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how JCR Pharmaceuticals Co Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with JCR Pharmaceuticals Co Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on JCR Pharmaceuticals Co Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP4273164A2 | Application | Verfahren und zusammensetzungen zur erhöhung der iduronat-2-sulfatase-aktivität im zns | C07K16/18; C07K16/2869; C07K2319/30; C12N9/16; A61K2039/505; C12Y301/06013; A61P25/28; C07K2317/565; C07K2317/92; A61K38/00; C07K2319/33 | November 08, 2023 |
| AU2022245592A9 | Application | Stable aqueous pharmaceutical composition or freeze-dried pharmaceutical composition | C12N15/62; C12N9/24; A61J1/05; A61K38/02; A61K38/43; A61K38/45; A61K38/46; A61K38/47; A61K38/48; A61K39/395; A61K45/00; A61K47/02; A61K47/10; A61K47/12; A61K47/18; A61K47/22; A61K47/26; A61K47/34; A61K47/65; A61K47/68; A61K9/08; A61K9/19; A61P25/00; A61P3/00; A61P43/00; C07K16/00; C07K16/28; C07K16/46 | October 26, 2023 |
| US20230323326A1 | Application | Mutant of alpha-n-acetylglucosaminidase | C12N15/52; C12N15/62; C12N9/2402; C12N9/2405; C12Y302/0105; C07K16/2881; C07K2319/30 | October 12, 2023 |
| US20230279156A1 | Application | Methods and compositions for increasing alpha-l-iduronidase activity in the cns | C12N9/0002; C12N9/2402; C12Y302/01076; A61K2039/505; A61K38/00; A61K47/6801; A61K47/6815; A61K47/6843; A61K47/6849; A61K9/0019; A61P25/00; A61P25/28; A61P43/00; C07K16/2869; C07K16/40; C07K16/46; C07K19/00; C07K2317/24; C07K2317/51; C07K2317/515; C07K2317/55; C07K2317/565; C07K2317/622; C07K2317/92; C07K2317/94; C07K2319/00 | September 07, 2023 |
| US11738068B2 | Grant | Protein-containing aqueous liquid formulation | A61K38/27; A61K38/43; A61K45/06; A61K47/10; A61K47/26; C07K16/2818; C07K16/2827 | August 29, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer